Can a protein calm the immune System's overreaction to cancer treatment?
Disease control
Terminated
This early-phase trial tests whether an experimental protein called CD24Fc can help people with advanced solid tumors recover from severe immune-related side effects caused by immunotherapy. These side effects occur when the immune system attacks healthy tissues. CD24Fc is design…
Phase: PHASE1, PHASE2 • Sponsor: Tianhong Li • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC